Extract of Rosmarinus officinalis L. leaves for pharmaceutical applications

US9011936B2 · kind B2 · utility

Assignee

• Naturex S.A. · FR

Inventors

• Kan He · River Edge, US
• Marc Roller · Le Pontet, FR
• Alvin Ibarra · Hoboken, US
• Naisheng Bai · Piscataway, US
• Jacques Dikansky · Avignon, FR

Key dates

• Filing date: Oct 16, 2009
• Grant date: Apr 21, 2015
• Expiry date: Jun 1, 2031

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K36/53
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed are methods of alleviating oxidative stress, regulating blood glucose levels, and controlling pancreatic lipase activity by administering a Rosemary extract. Such methods may be useful to help body weight and body fat, prevent obesity, and treat hyperglycemia, hyperinsulinemia, cardiovascular disease and Type-2 diabetes. Preferred extracts contain 20% or 50% carnosic acid.